BMY Clears Q2 With Room to Run—But Shorts Are Rebuilding Fast
Bristol-Myers Squibb reports Q2 earnings on July 30 with the stock at $63.60 and options traders notably relaxed — yet short interest has just posted its sharpest weekly jump in months, creating a quiet tension under…